Animal models to evaluate anti-atherosclerotic drugs

Raman P Priyadharsini1

  • 1Department of Pharmacology, JIPMER, Puducherry 605006, Tamil Nadu, India.

Insights

Preclinical atherosclerosis research needs better animal models. This review details current models, induction methods, and their pros and cons for drug development.

Area of Science:

  • Cardiovascular Research
  • Translational Medicine
  • Pharmacology

Background:

  • Atherosclerosis involves complex pathogenesis with endothelial injury and inflammation.
  • Statins, widely used for hypercholesterolemia, show limited efficacy, necessitating novel therapeutic strategies.
  • Effective preclinical evaluation of new atherosclerosis treatments requires suitable animal models.

Purpose of the Study:

  • To review existing animal models for atherosclerosis research.
  • To analyze methods of atherosclerosis induction in animal models.
  • To discuss the advantages, disadvantages, and current perspectives of these models for preclinical studies.

Main Methods:

  • Literature review of preclinical atherosclerosis studies.
  • Analysis of various animal models (rabbits, rats, mice, hamsters, mini pigs).
  • Categorization of induction methods: diet, chemical, mechanical, and genetic.

Main Results:

  • No single animal model perfectly replicates human atherosclerosis.
  • Each model (rabbits, rats, mice, etc.) presents unique advantages and limitations.
  • Diverse induction methods exist, each with specific outcomes and challenges.

Conclusions:

  • Selecting an appropriate animal model is critical for successful atherosclerosis drug development.
  • Understanding model-specific advantages and disadvantages is essential for interpreting preclinical data.
  • Further refinement of animal models is needed to better predict clinical efficacy of atherosclerosis therapies.